Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia

 Long-acting injectable antipsychotic treatment options for schizophrenia are part of the treatment plan but what are some of the barriers to their use? Professor John Kane and Dr Charlotte Emborg share their perspectives.

You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country